Jonathan Lippy
Jonathan Lippy leads a global team leveraging state-of-the-art automation and data technologies to deliver end-to-end capabilities with a focus on speed and portfolio impact across all therapeutic areas and modalities. With 29 years of experience in drug discovery, Jonathan has driven transformative strategies delivering next-generation AI-driven automation capabilities and workflows. Prior to joining J&J, Jonathan spent 22 years at Bristol-Myers Squibb, where he led the Kinome Hit-to-Leads Platform and Screening Operations team and was a member of the Discovery team for SOTYKTU®.